LINC02044

Across TCGA pan-cancer cohorts, LINC02044 RNA is linked to patient survival in 23 of 34 cancer types, making it the most broadly survival-associated LINC02044 data layer.

The strongest signal is observed in rectum adenocarcinoma (READ), where higher LINC02044 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated LINC02044 expression acts as an unfavorable survival marker, although some lineages such as READ and CESC show a favorable association.

READ, CESC, and PAAD are the cancer types where LINC02044 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
READ	DFS	Median	All	0.834	0.571	<.001	120	view →
CESC	OS	Quartile	All	0.931	0.729	<.001	50	view →
PAAD	OS	Quartile	All	0.577	0.222	<.001	45	view →
OV	DFS	Quartile	III,IV	0.463	0.594	.007	42	view →
ESCA	DFS	Tertile	II,III,IV	0.668	0.427	.007	41	view →
LGG	OS	Quartile	All	0.529	0.356	<.001	23	view →
DLBC	DFS	Median	III,IV	0.365	0.884	.021	22	view →
LIHC	OS	Tertile	II,III,IV	0.574	0.806	.008	18	view →
BRCA	DFS	Quartile	II,III,IV	0.922	0.963	.003	15	view →
KIRC	DFS	Median	IV	0.449	0.732	.019	15	view →
HNSC	DFS	Quartile	III,IV	0.359	0.203	.025	12	view →
THCA	DFS	Tertile	IV	0.916	0.471	.019	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 23 lineages.

LINC02044–READ (DFS)

Open the READ breakdown →